SunRegen Core Team | Experts in Drug Research & Development

Team

Our core team brings extensive experience in drug research and development and medical translation, having held senior scientist and business leadership positions at world-leading multinational pharmaceutical companies such as Novartis, Roche, Merck, Alcon, and Allergan, complemented by years of international work experience. Our esteemed scientific advisory team includes heavyweights such as the former Chief Scientist of Alzheimer’s Drug R&D at Novartis Switzerland Headquarters, a former VP of Drug R&D at Novartis Switzerland Headquarters, and a former VP of Retinal Research and Development at Alcon and Allergan.

David Guan

Chief Executive Officer

10 years of senior management experience at leading multinational companies, including Honeywell and HP.

Dr.Yuhong Dong

CS0

12 years of Pharma R&D research experience including as a Senior Medical Scientific Expert at Novartis Basel

David Guan

Managing Director, Chairman

David, with a Master’s degree in Electronic Engineering, brings a decade of senior management experience with multinational companies like Honeywell and HP. As an entrepreneur, he has successfully raised capital from international investors and demonstrated expertise in business operations, project management, and managing cross-cultural, multi-site teams.

Dr. Yuhong, Dong

Chairman, Director

Dr. Dong, holding both Medical Degree and Ph.D. in infectious disease from Beijing University, brings over 20 years of expertise in drug research and development across pharma and academia, excelling in infections, cancer, and neurological diseases. A recipient of four Novartis Awards with 30+ publications, she merges modern and traditional approaches to transform challenges into opportunities

Dr. Hubert Wong

Director

Dr. Hubert (Chiho) Wong is a registered general practitioner in both Hong Kong and mainland China. He holds a Master of Philosophy in Surgical Sciences and a Master of Science in Health Service Management from the Chinese University of Hong Kong. A dual fellow of the Hong Kong College of Health Service Executives and the Australian College of Healthcare Management, he brings extensive expertise to healthcare leadership.

Dr. Philip Bentley

DMPK and Toxicology Lead, Consultant

40 years of experience in the fields of drug metabolism and toxicology including V.P. & Global Head Preclinical Safety at Novartis

Dr. Thomas Hohman

Ophth Drug Development Expert

An established industry leader who oversaw the development of multiple ophthalmology therapies in Alcon, Allergan and Novartis for over 30 years.

Dr. Matthias Staufenbiel

Neurological Strategic Development Lead, Consultant

24+ years in leading positions at Novartis and Sandoz Preclinical Neuroscience Research focusing on neurodegenerative diseases

Dr. Hans-Jürgen Pfannkuche

Head of R&D

Pharmacovigilance Professional and Preclinical & Clinical Pharmacologist with 35 years of Team & Project Lead Expertise and thorough Experience in Drug Safety, Drug Discovery & Development, and Registration Affairs